Feb 13, 2024 / 12:00AM GMT
Presentation
Feb 13, 2024 / 12:00AM GMT
=====================
Corporate Participants
=====================
* Andy Schmeltz
CSL Limited - EVP of CSL Behring Business Unit
* Herve Gisserot
Vifor Pharma AG - Chief Commercial Officer
* Joy Carolyn Linton
CSL Limited - CFO
* Mark Dehring
CSL Limited - Head of IR
* Paul F. McKenzie
CSL Limited - MD, CEO & Executive Director
* Stephen Marlow
CSL Limited - Senior VP & GM of Seqirus
* William Mezzanotte
CSL Limited - Executive VP & Head of Research and Development
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Financial Services Pty Limited, Research Division - Senior Analyst
* Andrew Paine
CLSA Limited, Research Division - Research Analyst
* Craig Wong-Pan
RBC Capital Markets, Research Division - Director of Equity Research & Equity Research Analyst
* David Bailey
Macquarie Research - Analyst
*
CSL Ltd
(OTCPK:CSLLY)
$
19.98
-0.47 (-2.3%)
Market Cap: 37.96 Bil
Enterprise Value: 49.86 Bil
PE Ratio: 93.09
PB Ratio: 1.97
GF Score: 73/100 Half Year 2024 CSL Ltd Earnings Presentation Transcript
Feb 13, 2024 / 12:00AM GMT
Release Date Price:
$44.96
(-5.08%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot